Provide feedbackProvide feedback

Home :: Neurology

Study reveals potential role for fMRI-brain computer interface techniques in schizophrenia

Thursday, November 20 2008 | Comments
Evidence Grade 7 What's This?

By Kate Kahn A small study found that schizophrenic patients may be able to learn voluntary control over the insular cortex using a functional magnetic resonance imaging-based brain-computer interface (fMRI-BCI), and this technique could have a therapeutic application in this disorder. Brain-computer interfaces (BCI) measure brain activity online and are being investigated for use in different applications such as neurofeedback and control based on brain activity. Although most BCIs...

By Kate Kahn

A small study found that schizophrenic patients may be able to learn voluntary control over the insular cortex using a functional magnetic resonance imaging-based brain-computer interface (fMRI-BCI), and this technique could have a therapeutic application in this disorder.

Brain-computer interfaces (BCI) measure brain activity online and are being investigated for use in different applications such as neurofeedback and control based on brain activity. Although most BCIs used in humans have involved the use of electroencephalography and invasive techniques, fMRI-BCI is noninvasive and allows for higher spatial and temporal resolutions (Weiskopf et al, 2007).

Lead investigator Dr. Sergio Ruiz and colleagues from the Institute of Medical Psychology and Behavioral Neurobiology at the University of Tubingen in Germany, selected 4 stable patients with a DSM-IV schizophrenia diagnosis. Patients learned BCI by undergoing 10-14 feedback sessions that taught them how to control the Blood Oxygen Level Dependent (BOLD) signal from the left and right anterior insula. Subjects learned to increase activity of the anterior insula using visual feedback of the BOLD signal from the insula. All schizophrenic subjects were successful in learning how to regulate the BOLD magnitude in the right anterior insula. When compared with early sessions, later sessions showed improvement in the subjects' ability to regulate BOLD (P<.05).

Investigators also observed modulations in functional connectivity, which is typically decreased in schizophrenia. While early sessions showed that the inferior frontal gyrus was the major causal source in subjects, in later sessions investigators observed an increase in the causal density of functional connections of the network involved in self-regulation of emotions, areas related to cognitive control, attention, visual perception, and mental imagery.

Although small, this study is the first of its kind in attempting to train schizophrenic patients using fMRI-BCI neurofeedback techniques, the authors noted. The success achieved by these patients in learning volitional control of the insular cortex and modulation of functional connectivity may "open the door to therapeutic applications of this technique in schizophrenia." (Program 54.17, Poster AA8)

Latest News

PET scans show promise in detecting beta amyloid deposition in Alzheimer's disease Verusmed

Thursday, November 20 2008 | Comments
Evidence Grade 7 What's This?
By Kate Kahn

A new study provides further evidence that positron emission tomography (PET) imaging using the radiotracer Pittsburgh Compound B (PiB) may allow assessment of beta-amyloid deposition in the brains of patients with Alzheimer's disease.

While it has been previously demonstrated that PiB has...
Tags: Alzheimer's Disease & Dementia


MRI study sheds light on zolpidem's effects on neurochemistry, study shows Verusmed

Thursday, November 20 2008 | Comments
Evidence Grade 7 What's This?
By Kate Kahn

A new study suggested that acute administration of the nonbenzodiazepine hypnotic zolpidem in healthy individuals reduces thalamic GABA levels while increasing sedative and dysphoric effects.

Though behavioral effects of zolpidem are well documented, little is known about zolpidem's effects...
Tags: Insomnia


Preeclampsia associated with epilepsy in offspring, data show Verusmed

Wednesday, November 19 2008 | Comments
Evidence Grade 7 What's This?
Preeclampsia, like eclampsia, increases the risk for epilepsy in offspring, but this increased risk only seems to be significant among children born after 37 weeks of gestation, suggest findings from a population-based cohort study conducted in Denmark.

Investigators evaluated the association between preeclampsia or eclampsia and the incidence rate ratio (IRR) of epilepsy in >1.5 million children born between Jan. 1, 1978, and Dec. 2, 2004, with information collected from...

Sangamo BioSciences' SB-509 disappoints in Phase II diabetic neuropathy trial Verusmed

Wednesday, November 19 2008 | Comments
Evidence Grade 8 What's This?
Sangamo BioSciences Inc.'s SB-509 did not significantly differ from placebo in the first analysis of a Phase II diabetic neuropathy trial.

The double-blind SB-509-601 study involved 110 patients with mild to moderate diabetic peripheral sensory motor neuropathy in the legs. They were randomized to receive SB-509 30 mg or placebo in each leg every 2 months for 3 total treatments. The visual analog scale...





Neurology Conference Coverage